These findings underscore the crucial role of LIF in preventing GVHD through modulation of the STAT1/IL-12/MHC-II axis while supporting intestinal stem cell function and suppressing donor T cell infiltration and activation [101]. This evidence concerns the gene LIF and graft versus host disease.